Do I Need Chemotherapy for GIST?
Understanding Imatinib (Glivec) Treatment After Surgery
Do I need chemotherapy after GIST surgery?
This is one of the most common questions patients ask after being diagnosed with a gastrointestinal stromal tumour (GIST).
The short answer is:
Â
Not all patients require chemotherapy after GIST surgery.
Â
However, some patients may benefit from additional treatment in the form of targeted therapy, most commonly imatinib (Glivec).
Is imatinib chemotherapy?
Although often described as chemotherapy, imatinib is not a traditional chemotherapy drug.
It is a targeted therapy, which means it works by blocking specific proteins that allow tumour cells to grow.
Most GIST tumours are driven by mutations in proteins such as:
Â
- KIT
- PDGFRA
Imatinib blocks these signals, helping to reduce the risk of the tumour returning after surgery.
When is treatment needed after GIST surgery?
The decision to prescribe imatinib depends on the risk of recurrence.
Factors that influence this include:
- tumour size
- tumour location (stomach vs small intestine)
- mitotic rate (how quickly the tumour cells divide)
- whether the tumour ruptured
Patients with a higher risk of recurrence are more likely to benefit from post-operative treatment.
How long is Imatinib taken?
For patients who require treatment, Imatinib is usually taken:
daily for up to three years after surgery
Â
The exact duration depends on the individual risk profile and specialist recommendation.
What are the side effects of Imatinib?
One of the main concerns patients have is whether imatinib causes the same side effects as chemotherapy.
In general:
- imatinib is better tolerated than traditional chemotherapy
- it does not usually cause the typical severe side effects associated with chemotherapy
- however, side effects can still occur and should be monitored
How are patients monitored after GIST treatment?
After surgery and during imatinib treatment, patients are followed up carefully.
Monitoring typically includes:
- CT scans
- endoscopic examinations
- regular specialist review
This helps ensure there is no evidence of recurrence and that treatment remains effective.
When should I see a specialist?
You should seek specialist advice if:
- you have been diagnosed with a GIST
- you have been advised to consider surgery
- you are unsure whether you need treatment after surgery
- you want a second opinion
Specialist GIST care in London Ash Rohatgi
Mr Ash Rohatgi is a Consultant Upper Gastrointestinal Surgeon in London, specialising in the surgical treatment of conditions affecting the stomach and upper digestive tract.
Patients diagnosed with GIST benefit from:
- specialist surgical assessment
- personalised treatment planning
- access to minimally invasive and robotic surgery
- structured follow-up and multidisciplinary care
Frequently asked questions
No. Many patients are treated with surgery alone, while others may require imatinib depending on their risk of recurrence.
No. It is only recommended in patients with a higher risk of recurrence.
Imatinib can significantly reduce the risk of recurrence in patients who are considered high-risk.
Yes. GIST is considered a form of cancer, although its behaviour can vary widely between patients.
